BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1424 related articles for article (PubMed ID: 30292385)

  • 1. Characterization of virulence factors, antimicrobial resistance patterns and biofilm formation of Pseudomonas aeruginosa and Staphylococcus spp. strains isolated from corneal infection.
    Heidari H; Hadadi M; Sedigh Ebrahim-Saraie H; Mirzaei A; Taji A; Hosseini SR; Motamedifar M
    J Fr Ophtalmol; 2018 Nov; 41(9):823-829. PubMed ID: 30292385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens-associated corneal ulcers.
    Pinna A; Usai D; Sechi LA; Molicotti P; Zanetti S; Carta A
    Cornea; 2008 Apr; 27(3):320-6. PubMed ID: 18362661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic features of Pseudomonas aeruginosa isolates associated with eye infections referred to Farabi Hospital, Tehran, Iran.
    Doustdar F; Karimi F; Abedinyfar Z; Amoli FA; Goudarzi H
    Int Ophthalmol; 2019 Jul; 39(7):1581-1587. PubMed ID: 29982958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial resistance, biofilm-forming ability and virulence potential of Pseudomonas aeruginosa isolated from burn patients in northern Iran.
    Asadpour L
    J Glob Antimicrob Resist; 2018 Jun; 13():214-220. PubMed ID: 29421318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integron types, antimicrobial resistance genes, virulence gene profile, alginate production and biofilm formation in Iranian cystic fibrosis Pseudomonas aeruginosa isolates.
    Pournajaf A; Razavi S; Irajian G; Ardebili A; Erfani Y; Solgi S; Yaghoubi S; Rasaeian A; Yahyapour Y; Kafshgari R; Shoja S; Rajabnia R
    Infez Med; 2018 Sep; 26(3):226-236. PubMed ID: 30246765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biofilm-forming capacity of Staphylococcus epidermidis, Staphylococcus aureus, and Pseudomonas aeruginosa from ocular infections.
    Hou W; Sun X; Wang Z; Zhang Y
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5624-31. PubMed ID: 22736609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between antibiotic resistance, biofilm formation, genes coding virulence factors and source of origin of
    Ratajczak M; Kamińska D; Nowak-Malczewska DM; Schneider A; Dlugaszewska J
    Ann Agric Environ Med; 2021 Jun; 28(2):306-313. PubMed ID: 34184515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic phenotype and genotype of Pseudomonas aeruginosa isolates from spontaneous canine ocular infections.
    Ledbetter EC; Mun JJ; Kowbel D; Fleiszig SM
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):729-36. PubMed ID: 18836164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens- and non-contact lens-related keratitis.
    Choy MH; Stapleton F; Willcox MDP; Zhu H
    J Med Microbiol; 2008 Dec; 57(Pt 12):1539-1546. PubMed ID: 19018027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular detection of different virulence factors genes harbor pslA, pelA, exoS, toxA and algD among biofilm-forming clinical isolates of Pseudomonas aeruginosa.
    Farhan RE; Solyman SM; Hanora AM; Azab MM
    Cell Mol Biol (Noisy-le-grand); 2023 May; 69(5):32-39. PubMed ID: 37571905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biofilm forming capacity and antibiotic susceptibility of
    Kıvanç SA; Arık G; Akova-Budak B; Kıvanç M
    Malawi Med J; 2018 Dec; 30(4):243-249. PubMed ID: 31798802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis.
    Mannis MJ
    Trans Am Ophthalmol Soc; 2002; 100():243-71. PubMed ID: 12545697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Biofilm Formation, Psl Exopolysaccharide Expression, and Clinical Outcomes in Pseudomonas aeruginosa Keratitis: Analysis of Isolates in the Steroids for Corneal Ulcers Trial.
    Zegans ME; DiGiandomenico A; Ray K; Naimie A; Keller AE; Stover CK; Lalitha P; Srinivasan M; Acharya NR; Lietman TM
    JAMA Ophthalmol; 2016 Apr; 134(4):383-9. PubMed ID: 26846404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virulence attributes in Brazilian clinical isolates of Pseudomonas aeruginosa.
    Silva LV; Galdino AC; Nunes AP; dos Santos KR; Moreira BM; Cacci LC; Sodré CL; Ziccardi M; Branquinha MH; Santos AL
    Int J Med Microbiol; 2014 Nov; 304(8):990-1000. PubMed ID: 25127423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the anti-biofilm and antibacterial effects of Juglans regia L. extracts against clinical isolates of Pseudomonas aeruginosa.
    Dolatabadi S; Moghadam HN; Mahdavi-Ourtakand M
    Microb Pathog; 2018 May; 118():285-289. PubMed ID: 29605650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of biofilm production and characterization of genes encoding type III secretion system among Pseudomonas aeruginosa isolated from burn patients.
    Jabalameli F; Mirsalehian A; Khoramian B; Aligholi M; Khoramrooz SS; Asadollahi P; Taherikalani M; Emaneini M
    Burns; 2012 Dec; 38(8):1192-7. PubMed ID: 22995427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Broad-Spectrum Antimicrobial Combination for the Treatment of Staphylococcus aureus and Pseudomonas aeruginosa Corneal Infections.
    Chojnacki M; Philbrick A; Wucher B; Reed JN; Tomaras A; Dunman PM; Wozniak RAF
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30420484
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular characterization of multidrug-resistant (MDR) Pseudomonas aeruginosa isolated in a burn center.
    de Almeida Silva KCF; Calomino MA; Deutsch G; de Castilho SR; de Paula GR; Esper LMR; Teixeira LA
    Burns; 2017 Feb; 43(1):137-143. PubMed ID: 27595453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Virulence Factors and Antibiotic Resistance Pattern of Clinical and Intensive Care Unit Environmental Isolates of Pseudomonas aeruginosa.
    Zarei O; Mahmoudi H; Bardbari AM; Karami P; Alikhani MY
    Infect Disord Drug Targets; 2020; 20(5):758-762. PubMed ID: 31889501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Virulence Genes Associated with Type III Secretion System and Biofilm Formation in Pseudomonas aeruginosa Clinical Isolates.
    Ali ASBE; Ozler B; Baddal B
    Curr Microbiol; 2023 Oct; 80(12):389. PubMed ID: 37880467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 72.